Invesaro

Stocks TDAY Financial statements

Financial statements

USA TODAY Co., Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data USA TODAY Co., Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,2551,3421,5261,8683,4063,2082,9452,6642,5092,302
Cost of revenue7438651,0802,0341,9021,8601,6921,5461,411
Gross profit5996617881,3711,3071,085972964891
Selling, general and administrative4164475036021,000902852723704640
Operating income60.633.858.1-147-448109-33.686.3-42.8
Interest expense29.630.536.163.722913610811210597.2
Other non-operating income-1.62-34.3-38.1-60.2-258-197-43.3-92.4-34.826.3
Pre-tax income29.3-0.4320-207-706-87.9-76.9-6.17-77.7-1.28
Income tax-2.320.481.91-86-33.548.31.3521.7-51.3-3.03
Net income to minority interests-1.35-1.92-1.21-0.25-0.1-0.030.01
Net income31.6-0.9218.2-120-670-135-78-27.8-26.41.75
EBITDA128108143-35.1-184313148249113
EPS, basic0.70-0.020.31-1.77-5.09-1.00-0.57-0.20-0.180.01
EPS, diluted0.70-0.020.31-1.77-5.09-1.00-0.57-0.20-0.180.01
Shares, basic (weighted)45.2535867.7132135137140143145
Shares, diluted (weighted)45.35358.467.7132135137140143146
Dividend per share1.341.421.491.520.000.00

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents17243.148.715617113194.310010690.2
Receivables152174439314329289266240224
Inventory18.218.72555.135.137.745.226.820.912.9
Other current assets19.723.321.612911780.132.71518.816.6
Total current assets370263298779637577508444426389
Property, plant and equipment381373340816590415306239241178
Lease right-of-use assets0309290272233222144123
Goodwill228237311914534534533534530519
Intangible assets3514034861,013825713613524430338
Other non-current assets4.937.189.86113143
Total assets1,3361,2841,4444,0203,1092,8282,3942,1812,0401,837
Accounts payable19.115.816.6147132157189142154144
Accrued liabilities84.497110307
Deferred revenue7888.2105219186185154121108105
Short-term debt14.42.7212.43.312869.560.563.874.369.3
Total current liabilities196204248718741663617534546518
Long-term debt3393574281,6361,4721,1631,1019811,006885
Lease liabilities0298274255219204168146
Other non-current liabilities12.614.816.513615211710910112691.1
Total liabilities5816097253,0372,7462,2982,0981,8641,8881,683
Total debt3633684451,6361,6001,2321,1621,0451,080954
Paid-in capital7436837221,0911,1041,4001,4101,4261,2821,288
Retained earnings16.3-2.773.77-116-786-921-999-1,027-1,054-1,052
Treasury stock-0.42-1.08-1.87-2.88-4.9-8.15-14.7-17.4-20.5-23.6
Other comprehensive income-3.98-5.46-6.888.250.260-101-65.5-56.2-58.9
Shareholders' equity755674717981364532296318153155
Minority interests0-2.49-0.37-0.47-0.51-0.5
Total equity755674717981364530295317153155
Total liabilities and equity1,3361,2841,4444,0203,1092,8282,3942,1812,0401,837
Shares outstanding53.260.3129138142146149147147

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income31.6-0.9218.1-121-672-136-78.3-27.9-26.41.76
Depreciation and amortization67.874.484.8112264204182163156166
Stock-based compensation2.443.143.1611.326.418.416.816.612.59.15
Deferred income tax-2.86-0.520.23-87.8-30.2452.5511.5-44.8-10.3
Change in receivables14.94.980.0212.6112-33.244.934.125.817.2
Change in inventory-11.07-4.345.1520-2.82-7.4318.54.628.11
Change in payables4.99-4-2.533.96-66.4-33.5-23.7-65.1-1.93-20.5
Cash from operations94.811111025.557.812740.894.6100114
Capital expenditures-10.6-11.1-11.6-14-37-39.6-45.4-38.1-49.5-51.5
Acquisitions-137-164-205-7970-0.13-15.400
Sales and maturities of investments01.056.16
Cash from investing-145-160-201-78516070.622.147-288.97
Debt issued02079.71,792
Debt repaid-3.51-14.4-3.09-481
Stock issued136011100
Share buybacks-0.42-500-2.02-3.24-6.56-2.64-3.14-3.06
Dividends paid-59.8-75.6-87.2-91.900
Cash from financing72.1-79.798.5899-201-261-103-136-68.9-140
Exchange rate effect00-3.491.5-0.041.15-0.232.06-1.89
Net change in cash22-1296.6113618.1-63.1-38.85.815.57-18.4
Free cash flow84.299.497.911.620.887.9-4.656.550.862.9
Interest paid26.933.631.240.221810486.589.386.384.2
Income taxes paid2.60.051.271.19-3.96-8.323.418.2210.110.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $6.42 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin39.5%Gross profit / revenue.
Pre-tax margin3.0%Pre-tax income / revenue.
Net margin-1.8%Net income / revenue.
FCF margin2.8%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin5.1%Cash from operations / revenue.
Effective tax rate160.0%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)-26.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-2.2%Net income / average total assets.
SG&A / revenue27.5%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.3%Capital expenditures / revenue.
D&A / revenue6.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-8.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-7.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-7.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-7.5%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-6.3%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-8.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y14.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y41.0%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y14.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y23.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y24.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y1.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-19.4%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-15.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-9.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-8.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-10.0%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y2.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y2.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y2.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.81xCurrent assets / current liabilities.
Quick ratio0.62x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.17x(Cash + short-term investments) / current liabilities.
Debt / equity6.18xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets53.1%Total debt / total assets.
Liabilities / assets91.4%Total liabilities / total assets.
Net debt$863.4MTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital-$94.2MCurrent assets - current liabilities.
Goodwill and intangibles / assets46.1%(Goodwill + intangible assets) / total assets.
Tangible book value-$672.1MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.25xRevenue / average total assets.
Fixed asset turnover13.6xRevenue / average property, plant and equipment.
Inventory turnover106xCost of revenue / average inventory.
Days inventory3 days365 x average inventory / cost of revenue.
Receivables turnover10.1xRevenue / average receivables.
Days sales outstanding36 days365 x average receivables / revenue.
Days payables39 days365 x average accounts payable / cost of revenue.
Cash conversion cycle0 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow45.6%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.21Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$11.50Revenue / diluted weighted shares.
FCF per share$0.32Free cash flow / diluted weighted shares.
Operating cash flow per share$0.58Cash from operations / diluted weighted shares.
Book value per share$1.05Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$4.58Tangible book value / shares outstanding.
Cash per share$0.59(Cash + short-term investments) / shares outstanding.
Buybacks / FCF4.5%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$942.6MShare price x shares outstanding.
Enterprise value$1.81BMarket cap + total debt - cash - short-term investments.
P/S0.42xMarket cap / revenue.
P/B6.13xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF15.3xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF8.33xMarket cap / cash from operations, when positive.
EV/Sales0.81xEnterprise value / revenue.
EV/FCF29.3xEnterprise value / free cash flow, when both are positive.
FCF yield6.5%Free cash flow / market cap.
Earnings yield-4.3%Net income / market cap (the inverse of P/E).
Shareholder yield0.3%(Dividends paid + share buybacks) / market cap.
What was USA TODAY Co., Inc.'s revenue in fiscal 2025?

USA TODAY Co., Inc. reported revenue of $2.30B for fiscal 2025, 8.3% lower than the year before.

Was USA TODAY Co., Inc. profitable in fiscal 2025?

Yes. Net income was $1.7M, a net margin of 0.1%.

How much free cash flow did USA TODAY Co., Inc. generate in fiscal 2025?

Cash from operations of $114.4M minus capital expenditures of $51.5M left free cash flow of $62.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to USA TODAY Co., Inc.